Di Nuzzo Private Wealth, Inc. Guardant Health, Inc. Transaction History
Di Nuzzo Private Wealth, Inc.
- $700 Million
- Q4 2025
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 17 shares of GH stock, worth $1,604. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17
Previous 11
54.55%
Holding current value
$1,604
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding GH
# of Institutions
467Shares Held
125MCall Options Held
2.18MPut Options Held
2.69M-
Vanguard Group Inc Valley Forge, PA12.2MShares$1.15 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$1.06 Billion0.01% of portfolio
-
Invesco Ltd. Atlanta, GA4.93MShares$465 Million0.05% of portfolio
-
Baillie Gifford & CO4.89MShares$461 Million0.4% of portfolio
-
Capital International Investors Los Angeles, CA4.69MShares$443 Million0.05% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $9.65B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...